CareTrust REIT Schedules Third Quarter 2016 Earnings Call for Thursday, November 3, 2016

SAN CLEMENTE, Calif., Oct. 27, 2016 (GLOBE NEWSWIRE) -- CareTrust REIT, Inc. (Nasdaq: CTRE) announced today that it plans to release its third quarter 2016 financial results after the market closes on Wednesday, November 2, 2016. Representatives of CareTrust's management team will host a conference call to discuss the results the following day.

Conference Call

CareTrust invites current and prospective investors to tune in to its call on Thursday, November 3, 2016 at 12:00 p.m. Eastern Time (9:00 a.m. Pacific Time), during which CareTrust's management team will discuss the company's third quarter 2016 performance and other current matters. The dial-in number for this call is (844) 220-4972 (U.S.) or (317) 973-4053 (International). The conference ID number is 9812123.

To listen to the call online, or to view any financial or other statistical information required by SEC Regulation G, please visit the Investors section of the CareTrust website at http://investor.caretrustreit.com/. The call will be recorded, and will be available for replay via the website for 30 days following the call.

About CareTrustTM

CareTrust REIT, Inc. is a self-administered, publicly-traded real estate investment trust engaged in the ownership, acquisition and leasing of seniors housing and healthcare-related properties. With 149 net-leased healthcare properties and three operated seniors housing properties in 20 states, CareTrust pursues opportunities across the nation to acquire properties that will be leased to a diverse group of local, regional and national seniors housing operators, healthcare services providers, and other healthcare-related businesses. More information about CareTrust is available at www.caretrustreit.com.

CareTrust REIT, Inc.
(949) 542-3130
[email protected]

You May Also Be Interested In

• Fisker (FSR) files form 10-K, sees more job cuts, reiterates going concern doubts
• 10X Capital Venture Acquisition Corp. III (VCXB) Receives NYSE Notice Regarding Late Form 10-K Filing
• Centessa Pharmaceuticals (CNTA) Announces Pricing of $100 Million Public Offering of American Depositary Shares